Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of <scp>EBMT</scp>
Nicola Polverelli, Edouard F. Bonneville, Liesbeth C. de Wreede, Linda Köster, Nicolaus Kröger, Thomas Schroeder, Régis Peffault de Latour, Jakob Passweg, Katja Sockel, Annoek E. C. Broers, Andrew Clark, Peter Dreger, Didier Blaise, Ibrahim Yakoub‐Agha, Soeren Lykke Petersen, Jürgen Finke, Patrice Chevallier, Grzegorz Helbig, Werner Rabitsch, Simona Sammassimo, Luca Arcaini, Domenico Russo, Joanna Drozd‐Sokołowska, Kavita Raj, Marie Robin, Giorgia Battipaglia, Tomasz Czerw, Juan Carlos Hernández‐Boluda, Donal P. McLornan
Abstract
Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.